These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23377640)

  • 1. Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies.
    ; ;
    Am J Psychiatry; 2013 Feb; 170(2):207-17. PubMed ID: 23377640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
    Uher R; Perroud N; Ng MY; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Zagar T; Czerski PM; Jerman B; Larsen ER; Schulze TG; Zobel A; Cohen-Woods S; Pirlo K; Butler AW; Muglia P; Barnes MR; Lathrop M; Farmer A; Breen G; Aitchison KJ; Craig I; Lewis CM; McGuffin P
    Am J Psychiatry; 2010 May; 167(5):555-64. PubMed ID: 20360315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.
    Fabbri C; Tansey KE; Perlis RH; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Breen G; Curtis C; Sang-Hyuk L; Newhouse S; Patel H; Guipponi M; Perroud N; Bondolfi G; O'Donovan M; Lewis G; Biernacka JM; Weinshilboum RM; Farmer A; Aitchison KJ; Craig I; McGuffin P; Uher R; Lewis CM
    Pharmacogenomics J; 2018 May; 18(3):413-421. PubMed ID: 29160301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.
    Ising M; Lucae S; Binder EB; Bettecken T; Uhr M; Ripke S; Kohli MA; Hennings JM; Horstmann S; Kloiber S; Menke A; Bondy B; Rupprecht R; Domschke K; Baune BT; Arolt V; Rush AJ; Holsboer F; Müller-Myhsok B
    Arch Gen Psychiatry; 2009 Sep; 66(9):966-975. PubMed ID: 19736353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
    Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
    Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of antidepressant response: A polygenic approach.
    García-González J; Tansey KE; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Žagar T; Czerski PM; Jerman B; Buttenschøn HN; Schulze TG; Zobel A; Farmer A; Aitchison KJ; Craig I; McGuffin P; Giupponi M; Perroud N; Bondolfi G; Evans D; O'Donovan M; Peters TJ; Wendland JR; Lewis G; Kapur S; Perlis R; Arolt V; Domschke K; ; Breen G; Curtis C; Sang-Hyuk L; Kan C; Newhouse S; Patel H; Baune BT; Uher R; Lewis CM; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():128-134. PubMed ID: 28159590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genomewide association study of citalopram response in major depressive disorder.
    Garriock HA; Kraft JB; Shyn SI; Peters EJ; Yokoyama JS; Jenkins GD; Reinalda MS; Slager SL; McGrath PJ; Hamilton SP
    Biol Psychiatry; 2010 Jan; 67(2):133-8. PubMed ID: 19846067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide association study of a sustained pattern of antidepressant response.
    Hunter AM; Leuchter AF; Power RA; Muthén B; McGrath PJ; Lewis CM; Cook IA; Garriock HA; McGuffin P; Uher R; Hamilton SP
    J Psychiatr Res; 2013 Sep; 47(9):1157-65. PubMed ID: 23726668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics in major depression: a comprehensive meta-analysis.
    Niitsu T; Fabbri C; Bentini F; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
    Adkins DE; Clark SL; Åberg K; Hettema JM; Bukszár J; McClay JL; Souza RP; van den Oord EJ
    Transl Psychiatry; 2012 Jul; 2(7):e129. PubMed ID: 22760553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
    Wong ML; Dong C; Flores DL; Ehrhart-Bornstein M; Bornstein S; Arcos-Burgos M; Licinio J
    Am J Psychiatry; 2014 Dec; 171(12):1297-309. PubMed ID: 25220861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.
    Uher R; Perlis RH; Henigsberg N; Zobel A; Rietschel M; Mors O; Hauser J; Dernovsek MZ; Souery D; Bajs M; Maier W; Aitchison KJ; Farmer A; McGuffin P
    Psychol Med; 2012 May; 42(5):967-80. PubMed ID: 21929846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.
    Binder EB; Owens MJ; Liu W; Deveau TC; Rush AJ; Trivedi MH; Fava M; Bradley B; Ressler KJ; Nemeroff CB
    Arch Gen Psychiatry; 2010 Apr; 67(4):369-79. PubMed ID: 20368512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
    Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
    J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
    Paddock S; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ
    Am J Psychiatry; 2007 Aug; 164(8):1181-8. PubMed ID: 17671280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder.
    Cutler JA; Rush AJ; McMahon FJ; Laje G
    J Psychopharmacol; 2012 Mar; 26(3):360-7. PubMed ID: 22282879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
    McMahon FJ; Buervenich S; Charney D; Lipsky R; Rush AJ; Wilson AF; Sorant AJM; Papanicolaou GJ; Laje G; Fava M; Trivedi MH; Wisniewski SR; Manji H
    Am J Hum Genet; 2006 May; 78(5):804-814. PubMed ID: 16642436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide association studies of antidepressant outcome: a brief review.
    Laje G; McMahon FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1553-7. PubMed ID: 21115088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.
    Shiroma PR; Drews MS; Geske JR; Mrazek DA
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1140-8. PubMed ID: 23973251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.
    Perroud N; Uher R; Ng MY; Guipponi M; Hauser J; Henigsberg N; Maier W; Mors O; Gennarelli M; Rietschel M; Souery D; Dernovsek MZ; Stamp AS; Lathrop M; Farmer A; Breen G; Aitchison KJ; Lewis CM; Craig IW; McGuffin P
    Pharmacogenomics J; 2012 Feb; 12(1):68-77. PubMed ID: 20877300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.